Gufic Biosciences Q2 Results

  • BSE: 509079
  • NSE: GUFICBIO
  • ISIN: INE742B01025
  • Sector: Biotechnology & Drugs
BSE
416.0512.90 (3.20%)
Volume4.22 K
Updated: Mon 25 Nov, 2024 | 15:24:11
NSE
415.111.15 (2.76%)
Volume64.24 K
Updated: Mon 25 Nov, 2024 | 15:42:34
Today: 405.65
416.85
52-Wk: 278.00
501.10

Q2 Results Highlights

  • Total Income
    ₹204.18 Cr.
    (0.67%)
  • Operating Profit
    ₹34.32 Cr.
    (9.04%)
  • Profit After Tax
    ₹21.77 Cr.
    (4.38%)
  • Operating Margin
    16.81%
    (2.97%)
Note: Comparison is on YoY basis

Quarterly - Gufic Biosciences Q2 Results

*All figures in crores except per share values
Fiscal PeriodSep 24Jun 23QoQ CompSep 23YoY Comp
Total Revenue 204.18195.02-%214.87-%
Selling/ General/ Admin Expenses Total 28.4723.37-%26.78-%
Depreciation/ Amortization 4.304.24-%4.30-%
Other Operating Expenses Total 40.9639.33-%39.62-%
Total Operating Expense 169.86163.78-%179.80-%
Operating Income 34.3231.24-%35.07-%
Net Income Before Taxes 29.2528.05-%30.95-%
Net Income 21.7720.62-%23.21-%
Diluted Normalized EPS 2.172.13-%2.39-%

Recommended For You

    More Recommendations

    Trending Stocks

      Subscribe to Our Newsletter

      Get daily newsletters around different themes from livemint.

      Subscribe
      HomeMarketsPremiumInstant LoanMint Shorts